BiologicsMD, 3D Printed Comb and Thicker Eyebrows

Hair loss news first:

BiologicsMD

Update: October 18, 2022 — Dr. Brett King joins BiologicsMD as senior scientific advisor.

On July 30, it was announced that the University of Arkansas (along with several other entities) was issued a patent for a new hair loss drug based on work done by Dr. Joshua Sakon and three others. The patent is titled “Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone.”

Arkansas based privately held BiologicsMD holds the exclusive license to this technology. Their related hair loss drug will be known as BMD-2341. The related patent issued by the US Patent and Trademark Office is No. 9,062,300. The main portion of BiologisMD’s work entails bone growth, including for the spine, fracture repair and osteoporosis.

3D Printed Comb from Technion University

I am surprised that there has not been much new research coming from Israel when it comes to hair loss. The country has a booming start-up scene, and from my observations, Jewish people seem to suffer from baldness at an even higher rate than Caucasians (who in turn have much higher rates of baldness compared to Asians). In any case, this new 3D printed comb for hair loss project from Technion University in Israel seems interesting (you need to translate), although I would not be surprised if we never hear about it again. FYI — For any readers in Israel, here is an article from 2011 with names of local hair loss experts and clinics that you could consult.

Lumigan for Thicker Eyebrows

For several months, Spencer (aka Spex) has been experimenting with using Bimatoprost on his previously sparse eyebrows. He uses the Lumigan brand that is designed to reduce high pressure in the eyes. He recently added the above page on his site, and it is well worth checking out the before and after photos on there. Many hair loss sufferers have been waiting for months to hear about the delayed results of the clinical trials of Bimatoprost when used on scalp hair. While I have been skeptical that the drug will do much beyond what Minoxidil already does for scalp hair, Spex’s eyebrow results are very encouraging. Bimatoprost, if approved for use on the scalp, will entail a drastically higher dosage compared to what is used on eyebrows.

Other Hair Loss News this Month

— A very interesting radio interview with Dr. Luis Garza regarding his team’s latest groundbreaking findings on triggering organ and hair regeneration. See my recent post on those findings.

Samumed is recruiting for a 50-person supplemental clinical trial for its SM04554.

— George Cotsarelis gets yet one more patent approved (this one related to FGF-9 and hair growth). Filed in October 2014 and approved in August 2015.

— An optimistic conclusion from a molecular biologist: “In any case, I think that treatment for baldness is now a matter of quite a short period of time.” Article rambles a bit, perhaps because the writer is not a native English speaker.

— Some interesting thoughts on platelet-rich fibrin matrix from Dr. William Lindsey.

— In June, Dr. Alan Feller started a controversial thread on the HTN forum regarding strip (FUT) hair transplants still being more popular than FUE hair transplants. That thread has taken on a life of its own, and I only read it this month since I do not frequent those forums too often. Based on my own research (see FUE versus FUT hair transplants), I do not believe that strip will remain very popular. It already might be less popular than FUE, considering that doctors can now just purchase the ARTAS robot. They can then start practicing FUE with little past experience in doing so. In any case, Dr. Feller raises some interesting points in that thread, and I wonder if FUE transaction rates are really that high in the hands of experts? If I was getting a hair transplant today, I would go for FUE.

— A very useful update from a Japanese resident regarding AAPE and HARG treatment in Japan.

— An interesting study (on mice), where pluripotent stem cells from whisker follicles differentiate and grow into new hair when transplanted to the spinal cord.

— Comedian Matt Lucas has suffered from alopecia universalis for most of his life. A nice story on him helping a young boy suffering from the same here.

— Somewhat related to the above, scientists use cells created from hair follicles to repair damaged nerves.

And now on to medical items of interest:

Things are getting creepier and creepier and at the same time evermore mind-boggling each month.

Nearly complete brain developed in petri dish by Ohio State scientists. This was major news yesterday and today.

— United Therapeutics (Revivicor) is genetically engineering pigs in order to transplant their organs into humans. I find it absolutely fascinating that you can insert human genes into animals and that scientists are able to increase the number that they can insert every year. The founder and CEO of United Therapeutics is the amazing MTF transsexual Martine Rothblatt, who also co-founded Sirius XM satellite radio.

Young blood is what we all need.

Body-hackers. Worth clicking just to see the image.

— A pro designer baby article worth a skim-through. The Chinese will probably stab at this first.

A list of the top 11 3D-Bioprinting companies.

Person to Person Hair Transplants Revisited

Modern hair transplants generally produce quality results. However, the biggest disadvantage of hair restoration remains the fact that people have limited donor hair at the back of their scalps in the safe “permanent” zone.

Men with large bald areas will usually not get great results from a hair transplant unless their coverage expectations are modest. Meaning that they do not mind seeing barren scalp on days when their hair becomes wet in the rain or disheveled by the wind.

Hence the common question: “Can you transplant hair from one person to another?”. i.e., allogeneic hair transplants.

Person to Person Hair Transplants

Because of this lack of sufficient donor hair supply, one would wonder why person to person hair transplants have not become more common?

The obvious and most cited explanation from hair transplant surgeons is that due to the requirement of taking anti-rejection medications (immunosuppressants) for life, person to person hair transplants are almost never approved. Taking immunosuppressants for life carries significant health risks.

However, from what I have read in numerous organ transplant stories, death from taking anti-rejection drugs is rare. People monitor themselves daily when taking such drugs. I wonder how many people below the age of 60 die from the side effects of taking immunosuppressants?

Moreover, it seems like physicians are getting closer to weaning organ recipients off of immunosuppressants entirely. That would be a miracle. In any case, even if proven to be very safe in the long run, most people would not want to take immune supressing drugs just to get more scalp hair. Therefore, I was not planning on writing a post about person to person hair transplants.

Jahoda and Reynolds: First Successful Hair Transplant Between People

However, yesterday, I happened to reread the summary of a groundbreaking experiment from 1999 by Dr. Colin Jahoda on his wife Dr. Amanda Reynolds. The actual study was published in Nature.

Dr. Jahoda transplanted several of his scalp hairs to Dr. Reynolds arm, and four hairs then grew on Dr. Reynolds arm. I read about this well known experiment numerous times in the past, but forgot to ever check if Dr. Reynolds took immunosuppressants. Then I read the below in the above linked article and felt like a lightening bolt struck me:

Apart from its theoretical use in cosmetic medicine, the experiment reveals that: hair follicles are one of the rare tissues apparently capable of being transplanted from one body to another without rejection. Why evolution has endowed them with such “immune privilege” is a mystery.

This makes me wonder why more surgeons have not attempted person to person scalp hair to scalp hair transplants? In one of my pasts post on transplants and immunosuppressants, one commentator suggested that you could never get another living person to donate his or her hair to you. I think that is absolutely incorrect. If I had a very full thick head of hair and someone offered me say $100,000 to donate 20 percent of my scalp hair, I would be more than happy to do so. If it were a family member, I would do it for free.

Going back to the above article, it seems like Dr. Jahoda transferred dermal sheath cells rather than actual hair. However, the full hairs were extracted from Dr. Jahoda’s scalp prior to extraction of the dermal sheath cells from them via the use of a powerful microscope. Dr. Jahoda holds a patent on this procedure. The doctor did have some doubts about normal hair cycling feasibility after one round of shedding was over.

Success not Guaranteed

I was excited by my finding after re-reading the summary of the Jahoda experiment. Nevertheless, considering that it all happened in 1999, I think there must be some sound explanation behind person to person transplants never taking off.

I did some more googling on this, and came across an interesting comment from 2009 that is pasted below. Usually, I do not like to quote comments from internet based forum members. However, this one from Marion Landan on the regrowhair site seems somewhat legitimate and sincere to me:

“Just want to correct what you are saying about hair transplanting from another person. The people do not have to be identical twins or even related to one another. I have been told by a retiring hair transplant expert who tried some of these surgeries that sometimes it works and sometimes it does not.

Just as there was a learning curve for transfusing blood, there are things not understood about why hair can be transplanted sometimes from an unrelated donor, and sometimes can’t even be transplanted between identical twins (possibly with the twins the bald brother had an infection that caused his original hair loss, after transplantation from his brother, his head swelled up and rejected the new hair). I have also been told that hair transplanting between people was made illegal in the United States several years ago — so doctors no longer try it.”

Why would this have been made illegal? Were there serious side effects involved?

Reducing Rejection Rates after Transplant

Half of Dr. Siemionow’s prediction came true in 2015: first ever skull and scalp transplant.

Finally, it seems like certain commonalities between donor and recipient might increase the likelihood of survival of organs and tissues after a transplant. These can include blood type, certain common genes and more. Transplant survival rates with or without anti-rejection medication will continue to improve as researchers uncover more such details.